Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

Status:
Recruiting

Trial end date:
2022-04-27

Target enrollment:

Participant gender:

To assess the safety and tolerability of AMG 171 as single or multiple doses in subjects with obesity

Phase 1

Amgen